Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
PKI PerkinElmer
122.310
-0.920-0.75%
Post Mkt Price
122.3100.0000.00%
YOY
Do not show
Hide blank lines
(Q2)2022/07/03(Q1)2022/04/03(FY)2022/01/02(Q4)2022/01/02
Assets
Current assets
Cash, cash equivalents and short term investments
-37% 360.86M -32.23% 669.76M 53.8% 618.32M 53.8% 618.32M
-Cash and cash equivalents
-37% 360.86M -32.23% 669.76M 53.8% 618.32M 53.8% 618.32M
Receivables
-6.09% 932.13M -3.77% 941.72M -11.37% 1.02B -15.04% 1.02B
-Accounts receivable
-6.09% 932.13M -3.77% 941.72M -11.37% 1.02B -15.04% 1.02B
Inventory
21.59% 624.3M 21.89% 645.92M 21.41% 624.71M 21.41% 624.71M
Other current assets
5.15% 190.48M 10.84% 197.11M 4.04% 173.96M 4.04% 173.96M
Total current assets
-6.74% 2.11B -8.23% 2.45B 9.02% 2.44B 6.64% 2.44B
Non current assets
Net PPE
26.45% 742.98M 28.16% 749M 30.9% 753.38M 30.9% 753.38M
-Gross PPE
26.45% 742.98M 28.16% 749M 24.29% 1.27B -26.53% 753.38M
-Accumulated depreciation
-- -- -- -- -15.84% -521.17M -- --
Goodwill and other intangible assets
103.76% 11.01B 119.31% 11.31B 138.52% 11.48B 138.52% 11.48B
-Goodwill
88.43% 7.24B 99.99% 7.37B 115.15% 7.42B 115.15% 7.42B
-Other intangible assets
141.51% 3.77B 167.63% 3.94B 197.51% 4.06B 197.51% 4.06B
Other non current assets
-33.32% 324.25M -3.43% 334.79M -1.9% 326.71M 2.6% 341.71M
Total non current assets
86.46% 12.08B 103.57% 12.39B 119.52% 12.56B 119.79% 12.57B
Total assets
62.36% 14.19B 69.45% 14.85B 88.44% 15B 87.45% 15.02B
Liabilities
Current liabilities
Payables
2.77% 333.71M 11.01% 376.69M 5.11% 446.42M 8.59% 355.46M
-accounts payable
2.77% 333.71M 11.01% 376.69M 8.59% 355.46M 8.59% 355.46M
-Total tax payable
-- -- -- -- -6.61% 90.96M -- --
Current accrued expenses
-11.03% 705.92M 7.28% 882.63M 0.57% 364.95M -12.21% 870.65M
Current debt and capital lease obligation
-10.47% 4.18M -98.96% 3.73M -89.36% 44.81M -98.89% 4.24M
-Current debt
-10.47% 4.18M -98.96% 3.73M -98.89% 4.24M -98.89% 4.24M
-Current capital lease obligation
-- -- -- -- 0.59% 40.57M -- --
Current deferred liabilities
-- -- -- -- -22.9% 303.51M -- --
Current liabilities
-7.04% 1.04B -16.93% 1.26B -26.54% 1.21B -27.72% 1.23B
Non current liabilities
Long term debt and capital lease obligation
83.91% 4.67B 109.1% 5.04B 187.25% 5.17B 187.25% 5.17B
-Long term debt
90.94% 4.48B 119.13% 4.86B 209.36% 4.98B 209.36% 4.98B
-Long term capital lease obligation
-3.35% 182.99M -6.49% 180.11M -1.62% 185.36M -1.62% 185.36M
Non current deferred liabilities
-- 1.31B -- 1.35B -- 1.48B -- --
Other non current liabilities
-- -- -- -- -- -- 92.36% 1.49B
Total non current liabilities
77.05% 5.98B 97.51% 6.4B 158.32% 6.65B 158.68% 6.65B
Total liabilities
56.07% 7.02B 60.95% 7.66B 86.03% 7.86B 84.46% 7.89B
Shareholders'equity
Share capital
12.67% 126.22M 12.56% 126.14M 12.62% 126.24M -- --
-common stock
12.67% 126.22M 12.56% 126.14M 12.62% 126.24M -- --
-Preferred stock
-- 0 -- 0 -- 0 -- --
Retained earnings
15.54% 4.76B 18.22% 4.59B 25.94% 4.42B -- --
Paid-in capital
2553.4% 2.74B 2252.57% 2.72B 1763.95% 2.76B -- --
Gains losses not affecting retained earnings
-396.65% -459.09M -136.84% -246.72M -409.03% -162.69M -- --
Total stockholders'equity
69.04% 7.17B 79.56% 7.19B 91.17% 7.14B 90.88% 7.13B
Total equity
69.04% 7.17B 79.56% 7.19B 91.17% 7.14B 90.88% 7.13B
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
----Unqualified Opinion--

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment consists of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.
CEO: Dr. Prahlad R. Singh
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...